OSX Charts, page-25

I've been doing a fundamental analysis on this great company and below are what I gathered (totally my views based on fundamentals, dyor):

1) Resmed staff know what they are doing, and wouldn't join the company if they didn't see huge potential

2) A TGA approval would be 99.9% given since there is existing CE and FDA approvals, and TGA approval makes the ASX share prices fly.

3) Their products are one-of-a-kind, with huge increase in use of their technology

4) They have been manufacturing and selling these products for a long time

5) They have been leaders in this product family research since 2002

6) Their future is at least as great as what PNV achieved (went from 5 cents to $2.2 in 2 months) after approvals

7) They have clinical trials finishing very soon for Dental and Spinal and Orthopaedic and that means huge ASX news

8) New products above in the product pipeline which would mean fast De Novo FDA approvals (they have already approved devices with same materials)

I believe they are the next PNV and RAP but with already massive exisiting market and revenue and monopoly.